Skip to the main content

Original scientific paper

Post-thaw Viability of Cryopreserved Hematopoietic Progenitor Cell Grafts: Does It Matter?

Radovan Vrhovac ; University of Zagreb, School of Medicine, Zagreb, Croatia
Zinaida Perić ; Department of Medicine, University Hospital »Merkur«, Zagreb, Croatia
Silvana Jurenec ; Department of Transfusion Medicine, University Hospital »Merkur«, Zagreb, Croatia
Ika Kardum-Skelin ; University of Zagreb, School of Medicine, Zagreb, Croatia
Biljana Jelić-Puškarić ; Department of Medicine, University Hospital »Merkur«, Zagreb, Croatia
Branimir Jakšić ; University of Zagreb, School of Medicine, Zagreb, Croatia


Full text: english pdf 165 Kb

page 163-169

downloads: 2.371

cite


Abstract

Cell viability in peripheral blood progenitor cell (PBPC) grafts and its influence on the clinical course following transplantation was evaluated in 81 consecutive transplantations (72 autologous, 9 allogeneic) performed in patients with hematological diseases. Viability of cells in PBPC grafts immediately upon collection was 98.6±3.5%, after addition of dimethyl sulfoxide (DMSO) 73.3±21.8%, and post-thaw 65.2±16.1%. It did not differ significantly between patients with different diagnoses, gender, age, type of priming used, dose of G-CSF administered or number of CD34+ cells collected. However, grafts stored for more than 60 days showed lower post-thaw viability compared to the ones thawed in the 60 days following cryopreservation (56.6±15.2% vs. 67.6±15.5%, p=0.04). Post-thaw graft viability did not influence engraftment time, but there was a predisposition towards infectious complications in the post-transplant period in patients receiving grafts with lower percentage of viable cells. They developed febrile neutropenia more often (72.2% vs. 50% of patients, p=0.05) and had more febrile days (2.4±2.6 vs. 1.5±2.3, p=0.05) following transplantation. We have demonstrated that PBPC grafts are capable of long term engraftment regardless of the graft storage time or percentage of viable cells post-thaw, which confirms the robustness of CD34+ cells during the freeze/thaw procedures carried out in daily clinical practice. Granulocyte concentration in PBPC grafts could have an influence on infectious complications following transplantation and needs to be further investigated on a larger number of patients.

Keywords

hematopoietic progenitor cells; cryopreservation; viability

Hrčak ID:

51258

URI

https://hrcak.srce.hr/51258

Publication date:

10.3.2010.

Visits: 3.294 *